US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Completed

Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. D-0169-2020
Class II · Moderate risk Completed

Dr. Reddy's: Ranitidine Capsules 150 mg

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 55111-129-60 D-0168-2020
Class II · Moderate risk Terminated

Children's Ibuprofen Oral Suspension USP

Reason Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Taro Pharmaceuticals U.S.A., Inc. NDC 67091-321-04 D-0302-2020
Class II · Moderate risk Terminated

Children's Ibuprofen Oral Suspension USP

Reason Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Taro Pharmaceuticals U.S.A., Inc. NDC 51672-2130-1 D-0301-2020
Class II · Moderate risk Terminated

Children's Ibuprofen Oral Suspension USP

Reason Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Taro Pharmaceuticals U.S.A., Inc. NDC 51672-2130-8 D-0300-2020
Class II · Moderate risk Terminated

Ibuprofen Oral Suspension USP

Reason Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1385-9 D-0299-2020
Class II · Moderate risk Terminated

Ibuprofen Oral Suspension USP

Reason Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1385-8 D-0298-2020
Class II · Moderate risk Terminated

Estradiol tablets

Reason Presence of Foreign Tablets/Capsules: Estradiol 1 mg was found in a 100 count bottle of Estradiol 0.5 mg Tablets.

Epic Pharma, LLC NDC 42806-087-01 D-0135-2020
Class II · Moderate risk Terminated

Vivitrol

Reason Labeling: Not Elsewhere Classified. Drug product kit recalled due to 1 inch needles being placed in the 1 1/2 inch needle cardboard sleeve labelled as administration needles. The product vial is not impacted.

Alkermes, Inc. D-0119-2020
Class II · Moderate risk Terminated

DrKids Himasal Natural Nasal Saline Solution

Reason CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

Unipharma, Llc. D-0133-2020
Class II · Moderate risk Terminated

Prednisolone Sodium Phosphate Oral Solution

Reason Failed Impurities/Degradation Specifications - failed specs for Prednisolone Impurity 14

Morton Grove Pharmaceuticals, Inc. NDC 60432-212-08 D-0130-2020
Class II · Moderate risk Terminated

Phenylephrine Hydrochloride Ophthalmic Solution

Reason Lack of Assurance of Sterility: Out of specification results for container closure test which cannot guarantee the sterility of the product.

Akorn, Inc. NDC 17478-201-15 D-1883-2019
Class II · Moderate risk Terminated

Dextroamphetamine Sacharate

Reason Superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness.

Aurobindo Pharma USA Inc. NDC 13107-073-01 D-0143-2020
Class II · Moderate risk Ongoing

Losartan Potassium/ Hydrochlorothiazide Tablets

Reason CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million.

Torrent Pharma Inc. D-0124-2020